ARRAY BIOPHARMA INC Business Operations Contracts & Agreements
25 Contracts & Agreements
- Collaboration Agreements (14 contracts)
- Development Agreements (6)
- Sales Agreements (3)
- Termination Agreements (2)
- Sales Agreement between Array BioPharma Inc. and Jefferies LLC dated May 7, 2019 (Filed With SEC on May 7, 2019)
- Sales Agreement between Array BioPharma Inc. and Cantor Fitzgerald & Co. dated May 9, 2018 (Filed With SEC on May 9, 2018)
- CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT by and between Merck Sharp & Dohme B.V., and Array BioPharma, Inc. Dated: May 4, 2017 (Filed With SEC on August 11, 2017)
- AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on February 5, 2016)
- ARRAY BIOPHARMA INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 3 TO SALES AGREEMENT (Filed With SEC on November 6, 2015)
- AMENDMENT NO. 4 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on August 21, 2015)
- SEVENTH AMENDMENT TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on May 7, 2015)
- FIRST AMENDMENT TO TERMINATION AND ASSET TRANSFER AGREEMENT (Filed With SEC on May 7, 2015)
- TERMINATION AND ASSET TRANSFER AGREEMENT by and between NOVARTIS PHARMA AG, NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. and ARRAY BIOPHARMA INC. Dated as of November26, 2014 (Filed With SEC on February 4, 2015)
- AMENDMENT NO. 3 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on February 4, 2015)
- AMENDMENT NO. 2 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on August 15, 2014)
- AMENDMENT NO. 1 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on August 15, 2014)
- ARTICLE 1DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on August 12, 2013)
- DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on August 12, 2013)
- THIRD AMENDMENT TO DRUG DISCOVERY AND DEVELOPMENT AGREEMENT (Filed With SEC on February 6, 2013)
- SECOND AMENDMENT TO DRUG DISCOVERY AND DEVELOPMENT AGREEMENT (Filed With SEC on May 3, 2012)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 2, 2011)
- FIRST AMENDMENT TO DRUGDISCOVERY AND DEVELOPMENT AGREEMENT (Filed With SEC on August 18, 2009)
- FIFTH AMENDMENT TO DRUGDISCOVERY COLLABORATION AGREEMENT (Filed With SEC on November 4, 2008)
- FOURTH AMENDMENT TO DRUGDISCOVERY COLLABORATION AGREEMENT (Filed With SEC on November 4, 2008)
- DRUGDISCOVERY AND DEVELOPMENT AGREEMENT (Filed With SEC on November 6, 2007)
- SECOND AMENDMENT TO DRUGDISCOVERY COLLABORATION AGREEMENT (Filed With SEC on February 6, 2006)
- DRUGDISCOVERY COLLABORATION AGREEMENT (Filed With SEC on September 13, 2005)
- DRUG DISCOVERY COLLABORATION AGREEMENT BETWEEN GENENTECH, INC. AND ARRAY BIOPHARMA INC. (Filed With SEC on February 2, 2004)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on February 2, 2004)
